MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug trial offers hope for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial is testing a new antibody drug called GEN1042 to see if it's safe and can help control advanced solid tumors. Researchers are giving GEN1042 alone or combined with another cancer drug (pembrolizumab) to about 350 adults with cancers like lung, colorectal, m…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New cancer drug targets stomach and pancreatic tumors in early trial
Disease control OngoingThis early-stage study is testing a new drug called ASKB589 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and check if it can shrink tumors, especially in stomach…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New cancer drug begins first human tests in japan
Disease control OngoingThis early-stage study is testing a new cancer drug called GEN1042 in Japanese patients with advanced solid tumors. Researchers will first give GEN1042 alone to check safety, then test it combined with other cancer drugs. The main goal is to find safe doses and see how the body h…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC